Sartorius Stedim Biotech SA Stock Euronext Paris
Equities
STDM
FR0000053266
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- EUR | - |
Apr. 23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
Apr. 22 | Sartorius Stedim: in the red with brokerage comments | CF |
Sales 2024 * | 2.96B 3.16B | Sales 2025 * | 3.37B 3.61B | Capitalization | 20.31B 21.72B |
---|---|---|---|---|---|
Net income 2024 * | 343M 367M | Net income 2025 * | 459M 491M | EV / Sales 2024 * | 7.63 x |
Net Debt 2024 * | 2.25B 2.41B | Net Debt 2025 * | 2.14B 2.28B | EV / Sales 2025 * | 6.66 x |
P/E ratio 2024 * |
57.5
x | P/E ratio 2025 * |
41.3
x | Employees | - |
Yield 2024 * |
0.36% | Yield 2025 * |
0.53% | Free-Float | 31.97% |
Latest transcript on Sartorius Stedim Biotech SA
Managers | Title | Age | Since |
---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 48 | 19-03-25 |
Chairman | 59 | 07-06-28 | |
Chief Tech/Sci/R&D Officer | 59 | 09-04-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Henri Riey
BRD | Director/Board Member | 62 | 07-06-28 |
Chairman | 59 | 07-06-28 | |
Susan Dexter
BRD | Director/Board Member | 67 | 15-04-06 |
1st Jan change | Capi. | |
---|---|---|
-2.25% | 187B | |
-1.32% | 108B | |
-3.92% | 67.71B | |
+7.99% | 53.07B | |
+15.74% | 47.36B | |
+6.01% | 39.73B | |
+10.81% | 28.56B | |
+2.34% | 26.55B | |
+15.97% | 25.13B |
- Stock Market
- Equities
- DIM Stock
- STDM Stock